The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Immunotherapy (IT) with ch14.18/CHO for high-risk neuroblastoma: First results from the randomised HR-NBL1/SIOPEN trial.
Ruth L Ladenstein
Consultant or Advisory Role - Apeiron Biologics (U); Pierre Fabre Medicament (U)
Honoraria - Pierre Fabre Medicament
Research Funding - Apeiron Biologics; Pierre Fabre Medicament
Other Remuneration - Apeiron Biologics; Pierre Fabre Medicament
Ulrike Poetschger
No relevant relationships to disclose
Roberto Luksch
No relevant relationships to disclose
Penelope Brock
No relevant relationships to disclose
Victoria Castel
No relevant relationships to disclose
Isaac Yaniv
No relevant relationships to disclose
Vassilios Papadakis
No relevant relationships to disclose
Genevieve Laureys
No relevant relationships to disclose
Josef Malis
No relevant relationships to disclose
Walentyna Balwierz
No relevant relationships to disclose
Ellen Ruud
No relevant relationships to disclose
Per Kogner
No relevant relationships to disclose
Henrik Schroeder
No relevant relationships to disclose
Maja Beck Popovic
No relevant relationships to disclose
Peter F Ambros
No relevant relationships to disclose
Guenter Schreier
No relevant relationships to disclose
Holger N. Lode
No relevant relationships to disclose
Hans Loibner
Employment or Leadership Position - Apeiron Biologics
Stock Ownership - Apeiron Biologics
Andrew DJ Pearson
No relevant relationships to disclose
Dominique Valteau Couanet
No relevant relationships to disclose